Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits

被引:34
作者
Ok, Duck-Pil [1 ]
Ko, Kangeun [1 ]
Bae, Ju Yong [1 ]
机构
[1] Dong A Univ, Dept Phys Educ, Lab Exercise Biochem, Coll Arts & Phys Educ, 37 Nakdong Daero 550 Beon Gil, Busan 604714, South Korea
关键词
NAFLD; Training; CB1; receptor; AMPK; FAS; CPT1; CARDIOMETABOLIC RISK-FACTORS; HEPATIC CB1 RECEPTORS; METABOLIC SYNDROME; RIMONABANT; RESISTANCE; STEATOSIS; INSULIN; DYSLIPIDEMIA; ACTIVATION; OVERWEIGHT;
D O I
10.1186/s12944-018-0852-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: This study aimed to analyze the effect of exercise and/or dietary change on improvement of non-alcoholic fatty liver disease (NAFLD) in chronic high-fat diet (HFD)-induced obese mice. Methods: Forty male C57BL/6 (8 weeks old) mice were divided into normal diet (CO, n = 8) and high-fat diet (HF, n = 32) groups. The HF group was fed with 60% fat chow for 16 weeks to induce obesity. After the obesity induction period, the HF group was subdivided into HFD + sedentary (n = 8), HFD + training (HFT, n = 8), dietary change to normal-diet + sedentary (HFND, n = 8), and dietary change to normal-diet + training (HFNDT, n = 8) groups, and the mice in the training groups underwent treadmill training for 8 weeks, 5 times per week, 40 min per day. Results: A 24-week HFD induced increase of cannabinoid-1 receptor (CB1), fatty acid synthase (FAS), and AMP-activated protein kinase (AMPK) protein expressions (p < 0.05) and decrease of p-AMPK and carnitine palmitoyltransferase1 (CPT1) protein expressions (P < 0.05), resulting in increased liver fat accumulation. Treatment of exercise with dietary change and dietary change alone decreased CB1 and AMPK protein expressions with increased p-AMPK and CPT1 protein expressions (P < 0.05), leading to decreased body weight and liver fat (P < 0.05). The CB1 and FAS protein expressions in the HFT group were still higher than those in the CO group (P < 0.05), but the p-AMPK and CPT1 protein expressions were higher than those in the HF group (P < 0.05). Moreover, improved glucose tolerance and decreased liver fat were confirmed, although treatment of exercise alone had no effect on weight loss compared to pre-exercise. Conclusions: Even in the case of obesity induced by chronic HFD, exercise and/or dietary interventions have preventive and therapeutic effects on fat accumulation in the liver, resulting from upregulations of lipolytic factors. Therefore, the results of this study suggested that treatment of exercise alone without dietary change also leads to improvement of NAFLD and glucose tolerance without weight loss benefits.
引用
收藏
页数:7
相关论文
共 36 条
[1]   The role of endocannabinoids system in fatty liver disease and therapeutic potentials [J].
Alswat, Khalid A. .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (04) :144-151
[2]   The effects of detraining and training on adipose tissue lipid droplet in obese mice after chronic high-fat diet [J].
Bae, Ju Yong ;
Woo, Jinhee ;
Roh, Hee Tae ;
Lee, Yul Hyo ;
Ko, Kangeun ;
Kang, Sunghwun ;
Shin, Ki Ok .
LIPIDS IN HEALTH AND DISEASE, 2017, 16
[3]  
Bae Ju Yong, 2016, J Exerc Nutrition Biochem, V20, P28, DOI 10.20463/jenb.2016.06.20.2.4
[4]  
Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015
[5]   Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134
[6]   Peroxisome proliferator-activated receptor α ( PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice [J].
Fischer, M ;
You, M ;
Matsumoto, M ;
Crabb, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) :27997-28004
[7]   Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice [J].
Frederico, Marisa J. S. ;
Vitto, Marcelo F. ;
Cesconetto, Patricia A. ;
Engelmann, Julia ;
De Souza, Daniela R. ;
Luz, Gabrielle ;
Pinho, Ricardo A. ;
Ropelle, Eduardo R. ;
Cintra, Dennys E. ;
De Souza, Claudio T. .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (11) :1381-1388
[8]   Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats [J].
Gary-Bobo, Magali ;
Elachouri, Ghizlane ;
Gallas, Jean Francois ;
Janiak, Philip ;
Marini, Pietro ;
Ravinet-Triflou, Christine ;
Chabbert, Michele ;
Cruccioli, Noel ;
Pfersdorff, Christian ;
Roque, Claude ;
Arnone, Michele ;
Croci, Tiziano ;
Soubrie, Philippe ;
Oury-Donat, Florence ;
Maffrand, Jean Pierre ;
Scatton, Bernard ;
Lacheretz, Frederic ;
Le Fur, Gerard ;
Herbert, Jean Marc ;
Bensaid, Mohammed .
HEPATOLOGY, 2007, 46 (01) :122-129
[9]   Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis [J].
Golabi, Pegah ;
Bush, Haley ;
Younossi, Zobair M. .
CLINICS IN LIVER DISEASE, 2017, 21 (04) :739-753
[10]   Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis [J].
Hung, Chun Kit ;
Bodenheimer, Henry C., Jr. .
CLINICS IN LIVER DISEASE, 2018, 22 (01) :175-+